Cardiovascular Disease

Cardiac cell therapy has a long research history with uncertain results.

Studied for angiogenesis and reduced remodelling.

Small trials report safety findings.

Reported adverse events are mostly local — swelling, pain, or bruising at the harvest and injection sites. Infection and cell-processing quality remain the key risks to monitor.

Existing studies are limited by sample size, methodology, and follow-up, and SVF preparation differs substantially between centres, making cross-study comparison difficult.